✦ LIBER ✦

Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

✍ Scribed by Fenk, R; Hoyer, B; Steidl, U; Kondakci, M; Graef, T; Heuk, R; Ruf, L; Strupp, C; Neumann, F; Rohr, U-P; Hildebrandt, B; Haas, R; Kobbe, G

Book ID: 110056088
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 118 KB
Volume: 19
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of multiple myeloma

Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

✍ Zomas, A; Anagnostopoulos, N; Dimopoulos, M A 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB

Single nucleotide polymorphisms in the p

Single nucleotide polymorphisms in the promoter region of theIL1Bgene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

✍ Annette J. Vangsted; Tobias W. Klausen; Niels Abildgaard; Niels F. Andersen; Pet 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 509 KB

A phase II study of single agent paclita

A phase II study of single agent paclitaxel in patients at first relapse following initial chemotherapy for breast cancer

✍ N.G. Davidson; J.B. Chick; T.J. Perren; N. Campbell; J.M. Thompson; Y.T.S. Chan 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Efficient mobilization of peripheral blo

Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

✍ Ho, A D; Fruehauf, S; Klaus, J; Huesing, J; Veldwijk, M R; Buss, E C; Topaly, J; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB

Bortezomib, thalidomide, dexamethasone i

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

✍ Hyeon-Seok Eom; Yeo-Kyeoung Kim; Joo-Seop Chung; Kihyun Kim; Hyo Jung Kim; Ho Yo 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 153 KB

The combination of intermediate doses of

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio

✍ Terpos, E; Mihou, D; Szydlo, R; Tsimirika, K; Karkantaris, C; Politou, M; Voskar 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB